Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 1/1998

01-03-1998 | Article

Comparison of the effects of the antimetastatic compound ImH[trans-RuCl4(DMSO)Im] (NAMI-A) on the arthritic rat and on MCa mammary carcinoma in mice

Authors: Gianni Sava, Renato Gagliardi, Moreno Cocchietto, Katiuscia CLERICI, Ilaria Capozzi, Mauro Marrella, Enzo Alessio, Giovanni Mestroni, Roberto Milanino

Published in: Pathology & Oncology Research | Issue 1/1998

Login to get access
Metadata
Title
Comparison of the effects of the antimetastatic compound ImH[trans-RuCl4(DMSO)Im] (NAMI-A) on the arthritic rat and on MCa mammary carcinoma in mice
Authors
Gianni Sava
Renato Gagliardi
Moreno Cocchietto
Katiuscia CLERICI
Ilaria Capozzi
Mauro Marrella
Enzo Alessio
Giovanni Mestroni
Roberto Milanino
Publication date
01-03-1998
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 1/1998
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/BF02904692

Other articles of this Issue 1/1998

Pathology & Oncology Research 1/1998 Go to the issue

Case Report

Intravenous Leiomyomatosis of the Uterus

Article

Embryotoxicity and teratogenicity of some derivatives of chloroethylaminophenylacetic acid

Article

P53 Expression in stage I squamous cell lung cancer

Article

Cellular alterations upon IR-Laser (890 nm) exposures,In Vivo

Case Report

Carcinoid tumor of the middle ear in a 28-year-old patient

Article

Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits